Bloom Energy is scaling fuel cell capacity with major partnerships, while Eos Energy is ramping production amid heavy losses, each presents a starkly different risk profile.
Frontline (NYSE:FRO) reported its highest quarterly profit and adjusted profit on record for the second quarter of 2026, supported by sharply higher tanker rates and market inefficiencies that management said have tightened effective vessel supply.
The company posted net income of $659.2 million, o
Roivant Sciences (NASDAQ:ROIV) said the U.S. Food and Drug Administration has approved LISRAYA, its once-daily oral therapy for adults with dermatomyositis, and that the drug has already entered commercial launch.
Matt Gline, Roivant’s CEO, called the approval a significant milestone for patients w
BWX Technologies will build a 20-megawatt reactor at Fort Campbell under the Army's Janus program, shifting toward a vendor-owned power model backed by an $800 million divestiture and $8.39 billion backlog.
The surge in oil prices this year has boosted the energy giant's earnings. Here's why investors should continue to stay the course with the oil and gas stock.
Thompson's sale represents 23% of his direct equity stake, executed as the stock trades near its weighted average sale price despite a one-year decline.
Meta agreed to pay up to $18 billion to settle state youth social media addiction lawsuits, far below the roughly $200 billion in potential civil penalties cited by state plaintiffs.
Cytokinetics (NASDAQ:CYTK) presented primary results from its Phase III ACACIA-HCM trial evaluating aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, or nHCM, reporting that the study met its dual primary endpoints for patient-reported health status and exercise cap
Chagee (NASDAQ:CHA) reported second-quarter 2026 revenue growth and sharply higher profitability as the tea beverage company navigated a softer macroeconomic backdrop and intensifying competition in its core market.
Total revenue rose 2.5% year over year to RMB 3.41 billion, while GAAP net income r
Nano Labs (NASDAQ:NA) reported a wider net loss for the first half of 2026 as lower sales of its iPollo V Series products and a decline in the value of its cryptocurrency holdings weighed on results, while management outlined plans to expand its artificial intelligence and Web3-related product ecosy
